From proteomics to discovery of first-in-class ST2 inhibitors active in vivo-Reference-Cited by-同舟云学术

From proteomics to discovery of first-in-class ST2 inhibitors active in vivo

Published:2018-07-25 Issue:14 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Ramadan Abdulraouf M.,Daguindau Etienne,Rech Jason C.,Chinnaswamy Krishnapriya,Zhang Jilu^ORCID,Hura Greg L.,Griesenauer Brad^ORCID,Bolten Zachary,Robida Aaron,Larsen Martha,Stuckey Jeanne A.,Yang Chao-Yie^ORCID,Paczesny Sophie^ORCID

Funder

NIH/NCI

NIH/NIGMS

DOE/USA

NIH

University of Michigan

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/99208/files/pdf

Reference83 articles.

1. Homeostasis, Inflammation, and Disease Susceptibility

2. A guiding map for inflammation

3. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines

4. Molecular Mechanisms of Soluble Cytokine Receptor Generation

5. Soluble receptors in human disease

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inserting “OFF-to-ON” BODIPY Tags into Cytokines: A Fluorogenic Interleukin IL-33 for Real-Time Imaging of Immune Cells;ACS Central Science;2023-12-20

2. A Deep View of the Biological Property of Interleukin-33 and Its Dysfunction in the Gut;International Journal of Molecular Sciences;2023-08-31

3. Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl)pyrrole-Based Stimulation-2 (ST2) Inhibitors;ACS Pharmacology & Translational Science;2023-08-16

4. Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death;Journal of Clinical Investigation;2023-08-01

5. Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges;Frontiers in Immunology;2023-02-02